Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Mutations00:36

Viral Mutations

36.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
36.8K
Cross-reactivity00:42

Cross-reactivity

32.0K
Overview
32.0K
Humoral Immune Responses01:36

Humoral Immune Responses

79.6K
Overview
79.6K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

1.1K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.1K
Viral Recombination00:57

Viral Recombination

24.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.3K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

889
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
889

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The New Vaccine Surveillance Network: 25 years of active, population-based surveillance for pediatric infectious diseases in the United States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Complex structural variation, phylogeny, and disease associations of the mucin pangenome.

medRxiv : the preprint server for health sciences·2026
Same author

The Global Syphilis Epidemic: Turning the Tide.

Sexually transmitted diseases·2026
Same author

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same author

Influenza Antiviral Prescriptions in the US Inpatient and Outpatient Settings During the 2015-2022 Influenza Seasons.

Influenza and other respiratory viruses·2026
Same author

mRNA-based influenza vaccine expands the B cell response breadth in humans.

Nature immunology·2026

Related Experiment Video

Updated: Nov 9, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

12.0K

A human coronavirus evolves antigenically to escape antibody immunity.

Rachel T Eguia1, Katharine H D Crawford1,2,3, Terry Stevens-Ayers4

  • 1Basic Sciences and Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

Plos Pathogens
|April 8, 2021
PubMed
Summary

Human coronavirus 229E evolves to evade antibody immunity over time. This viral immune escape, driven by spike protein changes, suggests periodic updates for SARS-CoV-2 vaccines may be necessary.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.2K
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

7.9K

Related Experiment Videos

Last Updated: Nov 9, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

12.0K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.2K
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

7.9K

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Background:

  • Antibody immunity is crucial for controlling coronavirus infections.
  • The evolutionary capacity of coronaviruses to escape host immunity remains largely uncharacterized.

Purpose of the Study:

  • To investigate the historical evolution of human coronavirus 229E (HCoV-229E) and its ability to evade antibody immunity.
  • To determine the rate at which coronaviruses may evolve to escape pre-existing immunity.

Main Methods:

  • Characterization of historical HCoV-229E strains.
  • Neutralization assays using human sera from the 1980s and 1990s against contemporaneous and later HCoV-229E isolates.
  • Analysis of viral spike protein evolution, particularly the receptor-binding domain (RBD).

Main Results:

  • Human sera from the 1980s-1990s showed high neutralizing titers against contemporary HCoV-229E strains.
  • These sera exhibited significantly lower neutralizing titers against HCoV-229E strains isolated 8-17 years later.
  • Reduced neutralization was attributed to antigenic evolution in the viral spike protein, especially the RBD.

Conclusions:

  • HCoV-229E demonstrates significant antigenic evolution, allowing it to escape pre-existing antibody immunity over time.
  • This immune escape suggests a potential need for updated vaccines against other coronaviruses, including SARS-CoV-2, to maintain efficacy.